Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgos Bamias

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Digestive Diseases and Sciences|May 18, 2019
At the Junction of Immunity and Barrier Function: The Immunomodulatory Protein TL1A May Also Regulate Intestinal PermeabilityGiorgos Bamias
Digestion|April 22, 2010
Ability to reverse deeper levels of unintended sedationJohn Morse, Giorgos Bamias
Expert Review of Clinical Immunology|May 4, 2022
TL1A as a therapeutic target in inflammatory bowel diseaseGeorgios Kokkotis, Giorgos Bamias
Current Opinion in Gastroenterology|September 17, 2015
Role of type 2 immunity in intestinal inflammationGiorgos Bamias, Fabio Cominelli
Current Opinion in Gastroenterology|June 5, 2007
Immunopathogenesis of inflammatory bowel disease: current conceptsGiorgos Bamias, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2020
Exploring the Early Phase of Crohn's DiseaseGiorgos Bamias, Fabio Cominelli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2008
Balkan nephropathy: evolution of our knowledgeGiorgos Bamias, John Boletis
Current Opinion in Pharmacology|June 7, 2006
Novel strategies to attenuate immune activation in Crohn's diseaseGiorgos Bamias, Fabio Cominelli
Inflammatory Bowel Diseases|May 11, 2025
Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel DiseaseGeorgios Kokkotis, Giorgos Bamias
Current Opinion in Gastroenterology|September 28, 2016
Cytokines and intestinal inflammationGiorgos Bamias, Fabio Cominelli
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Digestive Diseases and Sciences|May 18, 2019
At the Junction of Immunity and Barrier Function: The Immunomodulatory Protein TL1A May Also Regulate Intestinal PermeabilityGiorgos Bamias
Digestion|April 22, 2010
Ability to reverse deeper levels of unintended sedationJohn Morse, Giorgos Bamias
Expert Review of Clinical Immunology|May 4, 2022
TL1A as a therapeutic target in inflammatory bowel diseaseGeorgios Kokkotis, Giorgos Bamias
Current Opinion in Gastroenterology|September 17, 2015
Role of type 2 immunity in intestinal inflammationGiorgos Bamias, Fabio Cominelli
Current Opinion in Gastroenterology|June 5, 2007
Immunopathogenesis of inflammatory bowel disease: current conceptsGiorgos Bamias, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2020
Exploring the Early Phase of Crohn's DiseaseGiorgos Bamias, Fabio Cominelli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2008
Balkan nephropathy: evolution of our knowledgeGiorgos Bamias, John Boletis
Current Opinion in Pharmacology|June 7, 2006
Novel strategies to attenuate immune activation in Crohn's diseaseGiorgos Bamias, Fabio Cominelli
Inflammatory Bowel Diseases|May 11, 2025
Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel DiseaseGeorgios Kokkotis, Giorgos Bamias
Current Opinion in Gastroenterology|September 28, 2016
Cytokines and intestinal inflammationGiorgos Bamias, Fabio Cominelli
Pageof 15